class name | count |
---|---|
rosids | 3 |
asterids | 2 |
class name | count |
---|---|
Enterobacteriaceae | 5 |
Brassicaceae | 2 |
Apiaceae | 1 |
Fabaceae | 1 |
Solanaceae | 1 |
Nocardiaceae | 1 |
br08003 Category | # of metabolite |
---|
br08003 Category | KEGG ID | KNApSAcK ID |
---|
KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
figure |
---|---|---|---|---|---|---|
C00001497
![]() |
3' 5'-cyclic AMP
|
CHEMBL9871
CHEMBL316966 CHEMBL1365681 CHEMBL1416083 CHEMBL1741513 CHEMBL2359042 |
D000242
|
29 / 24 / 19 | 80 / 7 |
![]() |
C00007445
![]() |
Adenosine 5'-phosphosulfate
|
CHEMBL578658
CHEMBL572546 |
D000250
|
![]() |
||
C00007446
![]() |
PAPS
/ 3'-phosphoadenosine 5'-phosphosulfate |
D010724
|
6 / 0 |
![]() |
||
C00018618
![]() |
B-Factor
/ 3'-(1-Butylphosphoryl)adenosine |
C044533
|
![]() |
|||
C00019347
![]() |
AMP
/ Adenosine 5'-phosphate |
CHEMBL16720
CHEMBL752 CHEMBL603811 CHEMBL608290 CHEMBL1230732 |
D000249
|
21 / 18 / 14 | 4 / 0 |
![]() |
C00019350
![]() |
3'-AMP
/ Adenosine 3'-phosphate |
CHEMBL576739
|
1 / 0 / 0 |
![]() |
||
C00019352
![]() |
Adenosine 3',5'-bisphosphate
|
CHEMBL416789
CHEMBL574817 |
C010840
|
1 / 1 / 1 |
![]() |
|
C00019673
![]() |
cGMP
/ Cyclic GMP / 3',5'-Cyclic GMP / Guanosine 3',5'-cyclic monophosphate |
CHEMBL68554
CHEMBL395336 |
D006152
|
9 / 3 / 2 | 11 / 7 |
![]() |
accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|
P49798 | Regulator of G-protein signaling 4 | Unclassified protein | C00001497 C00019347 | 2 / 0 |
Q96J66 | ATP-binding cassette sub-family C member 11 | Unclassified protein | C00001497 C00019673 | 1 / 0 |
O15440 | Multidrug resistance-associated protein 5 | Unclassified protein | C00001497 C00019673 | 0 / 0 |
Q96KQ7 | Histone-lysine N-methyltransferase EHMT2 | Enzyme | C00001497 C00019347 | 0 / 0 |
P28329 | Choline O-acetyltransferase | Enzyme | C00019347 C00019352 | 1 / 1 |
P30542 | Adenosine receptor A1 | Adenosine receptor | C00019347 C00019350 | 0 / 0 |
O15439 | Multidrug resistance-associated protein 4 | Unclassified protein | C00001497 C00019673 | 0 / 0 |
Q16280 | Cyclic nucleotide-gated olfactory channel | Unclassified protein | C00001497 C00019673 | 0 / 0 |
P05186 | Alkaline phosphatase, tissue-nonspecific isozyme | Enzyme | C00019347 | 3 / 1 |
Q9Y694 | Solute carrier family 22 member 7 | Unclassified protein | C00001497 | 0 / 0 |
P21589 | 5'-nucleotidase | Enzyme | C00019347 | 1 / 1 |
P10828 | Thyroid hormone receptor beta | NR1A2 | C00001497 | 3 / 1 |
P51582 | P2Y purinoceptor 4 | Purine receptor | C00019347 | 0 / 0 |
P25098 | Beta-adrenergic receptor kinase 1 | Bark | C00019673 | 0 / 0 |
P60891 | Ribose-phosphate pyrophosphokinase 1 | Enzyme | C00019347 | 4 / 4 |
P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | C00001497 | 0 / 1 |
P54132 | Bloom syndrome protein | Enzyme | C00001497 | 1 / 2 |
Q96G91 | P2Y purinoceptor 11 | Purine receptor | C00019347 | 0 / 0 |
P41231 | P2Y purinoceptor 2 | Purine receptor | C00019347 | 0 / 0 |
Q92830 | Histone acetyltransferase KAT2A | Enzyme | C00001497 | 0 / 0 |
O75496 | Geminin | Unclassified protein | C00001497 | 0 / 0 |
Q16281 | Cyclic nucleotide-gated cation channel alpha-3 | Unclassified protein | C00019673 | 1 / 1 |
Q8TCC7 | Solute carrier family 22 member 8 | Antiporter | C00001497 | 0 / 0 |
P02545 | Prelamin-A/C | Unclassified protein | C00001497 | 11 / 10 |
P07195 | L-lactate dehydrogenase B chain | Enzyme | C00019347 | 1 / 4 |
Q9Y253 | DNA polymerase eta | Enzyme | C00001497 | 1 / 1 |
P29973 | cGMP-gated cation channel alpha-1 | Unclassified protein | C00019673 | 1 / 1 |
Q03164 | Histone-lysine N-methyltransferase 2A | Enzyme | C00001497 | 1 / 2 |
O94782 | Ubiquitin carboxyl-terminal hydrolase 1 | Enzyme | C00001497 | 0 / 0 |
P00338 | L-lactate dehydrogenase A chain | Enzyme | C00019347 | 1 / 5 |
P12931 | Proto-oncogene tyrosine-protein kinase Src | Src | C00019347 | 0 / 0 |
P09467 | Fructose-1,6-bisphosphatase 1 | Enzyme | C00019347 | 1 / 1 |
P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | C00001497 | 0 / 0 |
P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | C00001497 | 1 / 1 |
P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | C00001497 | 0 / 1 |
Q6W5P4 | Neuropeptide S receptor | Neuropeptide receptor | C00001497 | 1 / 0 |
Q6DHV7 | Adenosine deaminase-like protein | Enzyme | C00019347 | 0 / 0 |
Q13526 | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | Enzyme | C00001497 | 0 / 0 |
P47900 | P2Y purinoceptor 1 | Purine receptor | C00019347 | 0 / 0 |
P21728 | D(1A) dopamine receptor | Dopamine receptor | C00001497 | 0 / 0 |
Q8WZA2 | Rap guanine nucleotide exchange factor 4 | Unclassified protein | C00001497 | 0 / 0 |
P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | C00001497 | 1 / 0 |
Q08493 | cAMP-specific 3',5'-cyclic phosphodiesterase 4C | PDE_4C | C00001497 | 0 / 0 |
Q07343 | cAMP-specific 3',5'-cyclic phosphodiesterase 4B | PDE_4B | C00001497 | 0 / 0 |
P27815 | cAMP-specific 3',5'-cyclic phosphodiesterase 4A | PDE_4A | C00001497 | 0 / 0 |
Q08499 | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | PDE_4D | C00001497 | 1 / 0 |
Q9UBF8 | Phosphatidylinositol 4-kinase beta | Enzyme | C00019347 | 0 / 0 |
Q8TCG2 | Phosphatidylinositol 4-kinase type 2-beta | Enzyme | C00019347 | 0 / 0 |
Q9BTU6 | Phosphatidylinositol 4-kinase type 2-alpha | Enzyme | C00019347 | 0 / 0 |
P42356 | Phosphatidylinositol 4-kinase alpha | Enzyme | C00019347 | 0 / 0 |
Q16637 | Survival motor neuron protein | Unclassified protein | C00019347 | 4 / 1 |
Q13370 | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | PDE_3B | C00019673 | 0 / 0 |
Q14432 | cGMP-inhibited 3',5'-cyclic phosphodiesterase A | PDE_3A | C00019673 | 0 / 0 |
gene | gene name | gene description | KNApSAcK metabolite in interactions |
---|---|---|---|
10257 | ABCC4, EST170205, MOAT-B, MOATB, MRP4 | ATP-binding cassette, sub-family C (CFTR/MRP), member 4 |
C00001497
C00019673
|
5152 | PDE9A, HSPDE9A2 | phosphodiesterase 9A (EC:3.1.4.35) |
C00001497
C00019673
|
50940 | PDE11A, PPNAD2 | phosphodiesterase 11A (EC:3.1.4.35 3.1.4.17) |
C00001497
C00019673
|
10846 | PDE10A, HSPDE10A | phosphodiesterase 10A (EC:3.1.4.35 3.1.4.17) |
C00001497
C00019673
|
6648 | SOD2, IPOB, MNSOD, MVCD6 | superoxide dismutase 2, mitochondrial (EC:1.15.1.1) |
C00001497
|
155 | ADRB3, BETA3AR | adrenoceptor beta 3 |
C00001497
|
250 | ALPP, ALP, PALP, PLAP, PLAP-1 | alkaline phosphatase, placental (EC:3.1.3.1) |
C00001497
|
551 | AVP, ADH, ARVP, AVP-NPII, AVRP, VP | arginine vasopressin |
C00001497
|
554 | AVPR2, ADHR, DI1, DIR, DIR3, NDI, V2R | arginine vasopressin receptor 2 |
C00001497
|
673 | BRAF, B-RAF1, BRAF1, NS7, RAFB1 | v-raf murine sarcoma viral oncogene homolog B (EC:2.7.11.1) |
C00001497
|
796 | CALCA, CALC1, CGRP, CGRP-I, CGRP1, CT, KC | calcitonin-related polypeptide alpha |
C00001497
|
10498 | CARM1, PRMT4 | coactivator-associated arginine methyltransferase 1 (EC:2.1.1.125) |
C00001497
|
595 | CCND1, BCL1, D11S287E, PRAD1, U21B31 | cyclin D1 |
C00001497
|
1027 | CDKN1B, CDKN4, KIP1, MEN1B, MEN4, P27KIP1 | cyclin-dependent kinase inhibitor 1B (p27, Kip1) |
C00001497
|
1080 | CFTR, ABC35, ABCC7, CF, CFTR/MRP, MRP7, TNR-CFTR, dJ760C5.1 | cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7) (EC:3.6.3.49) |
C00001497
|
1081 | CGA, CG-ALPHA, FSHA, GPHA1, GPHa, HCG, LHA, TSHA | glycoprotein hormones, alpha polypeptide |
C00001497
|
1082 | CGB, CGB3, CGB5, CGB7, CGB8, hCGB | chorionic gonadotropin, beta polypeptide |
C00001497
|
1268 | CNR1, CANN6, CB-R, CB1, CB1A, CB1K5, CB1R, CNR | cannabinoid receptor 1 (brain) |
C00001497
|
1269 | CNR2, CB-2, CB2, CX5 | cannabinoid receptor 2 (macrophage) |
C00001497
|
1387 | CREBBP, CBP, KAT3A, RSTS | CREB binding protein (EC:2.3.1.48) |
C00001497
|
1392 | CRH, CRF | corticotropin releasing hormone |
C00001497
|
1394 | CRHR1, CRF-R, CRF-R-1, CRF-R1, CRF1, CRFR-1, CRFR1, CRH-R-1, CRH-R1, CRH-R1h, CRHR, CRHR1L, CRHR1f | corticotropin releasing hormone receptor 1 |
C00001497
|
1440 | CSF3, C17orf33, CSF3OS, GCSF, G-CSF | colony stimulating factor 3 (granulocyte) |
C00001497
|
1584 | CYP11B1, CPN1, CYP11B, FHI, P450C11 | cytochrome P450, family 11, subfamily B, polypeptide 1 (EC:1.14.15.4) |
C00001497
|
1586 | CYP17A1, CPT7, CYP17, P450C17, S17AH | cytochrome P450, family 17, subfamily A, polypeptide 1 (EC:1.14.99.9 4.1.2.30) |
C00001497
|
27185 | DISC1, C1orf136, SCZD9 | disrupted in schizophrenia 1 |
C00001497
|
22943 | DKK1, DKK-1, SK | dickkopf WNT signaling pathway inhibitor 1 |
C00001497
|
1812 | DRD1, DADR, DRD1A | dopamine receptor D1 |
C00001497
|
1813 | DRD2, D2DR, D2R | dopamine receptor D2 |
C00001497
|
2099 | ESR1, ER, ESR, ESRA, ESTRR, Era, NR3A1 | estrogen receptor 1 |
C00001497
|
2100 | ESR2, ER-BETA, ESR-BETA, ESRB, ESTRB, Erb, NR3A2 | estrogen receptor 2 (ER beta) |
C00001497
|
2150 | F2RL1, GPR11, PAR2 | coagulation factor II (thrombin) receptor-like 1 |
C00001497
|
2353 | FOS, AP-1, C-FOS, p55 | FBJ murine osteosarcoma viral oncogene homolog |
C00001497
|
2488 | FSHB | follicle stimulating hormone, beta polypeptide |
C00001497
|
2668 | GDNF, ATF1, ATF2, HFB1-GDNF, HSCR3 | glial cell derived neurotrophic factor |
C00001497
|
2778 | GNAS, AHO, C20orf45, GNAS1, GPSA, GSA, GSP, NESP, PHP1A, PHP1B, PHP1C, POH | GNAS complex locus |
C00001497
|
338442 | HCAR2, GPR109A, HCA2, HM74a, HM74b, NIACR1, PUMAG, Puma-g | hydroxycarboxylic acid receptor 2 |
C00001497
|
8843 | HCAR3, GPR109B, HCA3, HM74, PUMAG, Puma-g | hydroxycarboxylic acid receptor 3 |
C00001497
|
3269 | HRH1, H1-R, hisH1 | histamine receptor H1 |
C00001497
|
3274 | HRH2, H2R | histamine receptor H2 |
C00001497
|
3284 | HSD3B2, HSD3B, HSDB, SDR11E2 | hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2 (EC:1.1.1.145 5.3.3.1) |
C00001497
|
3350 | HTR1A, 5-HT-1A, 5-HT1A, 5HT1a, ADRB2RL1, ADRBRL1, G-21, PFMCD | 5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupled |
C00001497
|
3351 | HTR1B, 5-HT1B, 5-HT1DB, HTR1D2, HTR1DB, S12 | 5-hydroxytryptamine (serotonin) receptor 1B, G protein-coupled |
C00001497
|
3363 | HTR7, 5-HT7 | 5-hydroxytryptamine (serotonin) receptor 7, adenylate cyclase-coupled |
C00001497
|
3592 | IL12A, CLMF, IL-12A, NFSK, NKSF1, P35 | interleukin 12A (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35) |
C00001497
|
3593 | IL12B, CLMF, CLMF2, IL-12B, NKSF, NKSF2 | interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40) |
C00001497
|
3553 | IL1B, IL-1, IL1-BETA, IL1F2 | interleukin 1, beta |
C00001497
|
3576 | IL8, CXCL8, GCP-1, GCP1, LECT, LUCT, LYNAP, MDNCF, MONAP, NAF, NAP-1, NAP1 | interleukin 8 |
C00001497
|
3624 | INHBA, EDF, FRP | inhibin, beta A |
C00001497
|
3725 | JUN, AP-1, AP1, c-Jun | jun proto-oncogene |
C00001497
|
3952 | LEP, LEPD, OB, OBS | leptin |
C00001497
|
3972 | LHB, CGB4, LSH-B, hLHB | luteinizing hormone beta polypeptide |
C00001497
|
3973 | LHCGR, HHG, LCGR, LGR2, LH/CG-R, LH/CGR, LHR, LHRHR, LSH-R, ULG5 | luteinizing hormone/choriogonadotropin receptor |
C00001497
|
3991 | LIPE, HSL, LHS | lipase, hormone-sensitive (EC:3.1.1.79) |
C00001497
|
4158 | MC2R, ACTHR | melanocortin 2 receptor (adrenocorticotropic hormone) |
C00001497
|
54539 | NDUFB11, CI-ESSS, ESSS, NP17.3, Np15, P17.3 | NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 11, 17.3kDa |
C00001497
|
4988 | OPRM1, LMOR, M-OR-1, MOP, MOR, MOR1, OPRM | opioid receptor, mu 1 |
C00001497
|
153 | ADRB1, ADRB1R, B1AR, BETA1AR, RHR | adrenoceptor beta 1 |
C00001497
|
9370 | ADIPOQ, ACDC, ACRP30, ADIPQTL1, ADPN, APM-1, APM1, GBP28 | adiponectin, C1Q and collagen domain containing |
C00001497
|
5142 | PDE4B, DPDE4, PDE4B5, PDEIVB | phosphodiesterase 4B, cAMP-specific (EC:3.1.4.17) |
C00001497
|
5150 | PDE7A, HCP1, PDE7 | phosphodiesterase 7A (EC:3.1.4.17) |
C00001497
|
27115 | PDE7B, bA472E5.1 | phosphodiesterase 7B (EC:3.1.4.17) |
C00001497
|
5151 | PDE8A, HsT19550 | phosphodiesterase 8A (EC:3.1.4.17) |
C00001497
|
8622 | PDE8B, ADSD, PPNAD3 | phosphodiesterase 8B (EC:3.1.4.17) |
C00001497
|
116 | ADCYAP1, PACAP | adenylate cyclase activating polypeptide 1 (pituitary) |
C00001497
|
5617 | PRL | prolactin |
C00001497
|
84432 | PROK1, EGVEGF, PK1, PRK1 | prokineticin 1 |
C00001497
|
5739 | PTGIR, IP, PRIPR | prostaglandin I2 (prostacyclin) receptor (IP) |
C00001497
|
5744 | PTHLH, BDE2, HHM, PLP, PTHR, PTHRP | parathyroid hormone-like hormone |
C00001497
|
5908 | RAP1B, K-REV, RAL1B | RAP1B, member of RAS oncogene family |
C00001497
|
9376 | SLC22A8, OAT3 | solute carrier family 22 (organic anion transporter), member 8 |
C00001497
|
6518 | SLC2A5, GLUT-5, GLUT5 | solute carrier family 2 (facilitated glucose/fructose transporter), member 5 |
C00001497
|
154 | ADRB2, ADRB2R, ADRBR, B2AR, BAR, BETA2AR | adrenoceptor beta 2, surface |
C00001497
|
7031 | TFF1, BCEI, D21S21, HP1.A, HPS2, pNR-2, pS2 | trefoil factor 1 |
C00001497
|
7124 | TNF, DIF, TNF-alpha, TNFA, TNFSF2 | tumor necrosis factor |
C00001497
|
7252 | TSHB, TSH-B, TSH-BETA | thyroid stimulating hormone, beta |
C00001497
|
7253 | TSHR, CHNG1, LGR3, hTSHR-I | thyroid stimulating hormone receptor |
C00001497
|
7432 | VIP, PHM27 | vasoactive intestinal peptide |
C00001497
|
7434 | VIPR2, C16DUPq36.3, DUP7q36.3, PACAP-R-3, PACAP-R3, VIP-R-2, VPAC2, VPAC2R, VPCAP2R | vasoactive intestinal peptide receptor 2 |
C00001497
|
7474 | WNT5A, hWNT5A | wingless-type MMTV integration site family, member 5A |
C00001497
|
216 | ALDH1A1, ALDC, ALDH-E1, ALDH1, ALDH11, PUMB1, RALDH1 | aldehyde dehydrogenase 1 family, member A1 (EC:1.2.1.36) |
C00019347
|
170685 | NUDT10, APS2, DIPP3a, hDIPP3alpha | nudix (nucleoside diphosphate linked moiety X)-type motif 10 (EC:3.6.1.52 3.6.1.60) |
C00019347
|
55190 | NUDT11, APS1, ASP1, DIPP3b, DIPP3beta, hDIPP3beta | nudix (nucleoside diphosphate linked moiety X)-type motif 11 (EC:3.6.1.52 3.6.1.60) |
C00019347
|
10891 | PPARGC1A, LEM6, PGC-1(alpha), PGC-1v, PGC1, PGC1A, PPARGC1 | peroxisome proliferator-activated receptor gamma, coactivator 1 alpha |
C00019347
|
217 | ALDH2, ALDH-E2, ALDHI, ALDM | aldehyde dehydrogenase 2 family (mitochondrial) (EC:1.2.1.3) |
C00019673
|
5604 | MAP2K1, CFC3, MAPKK1, MEK1, MKK1, PRKMK1 | mitogen-activated protein kinase kinase 1 (EC:2.7.12.2) |
C00019673
|
5605 | MAP2K2, CFC4, MAPKK2, MEK2, MKK2, PRKMK2 | mitogen-activated protein kinase kinase 2 (EC:2.7.12.2) |
C00019673
|
5599 | MAPK8, JNK, JNK-46, JNK1, JNK1A2, JNK21B1/2, PRKM8, SAPK1, SAPK1c | mitogen-activated protein kinase 8 (EC:2.7.11.24) |
C00019673
|
4878 | NPPA, ANF, ANP, ATFB6, CDD-ANF, PND | natriuretic peptide A |
C00019673
|
8654 | PDE5A, CGB-PDE, CN5A, PDE5 | phosphodiesterase 5A, cGMP-specific (EC:3.1.4.35) |
C00019673
|
6794 | STK11, LKB1, PJS, hLKB1 | serine/threonine kinase 11 (EC:2.7.11.1) |
C00019673
|
10 | NAT2, AAC2, NAT-2, PNAT | N-acetyltransferase 2 (arylamine N-acetyltransferase) (EC:2.3.1.5) |
C00007446
|
1728 | NQO1, DHQU, DIA4, DTD, NMOR1, NMORI, QR1 | NAD(P)H dehydrogenase, quinone 1 (EC:1.6.5.2) |
C00007446
|
6817 | SULT1A1, HAST1/HAST2, P-PST, PST, ST1A1, ST1A3, STP, STP1, TSPST1 | sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1 (EC:2.8.2.1) |
C00007446
|
6799 | SULT1A2, HAST4, P-PST, ST1A2, STP2, TSPST2 | sulfotransferase family, cytosolic, 1A, phenol-preferring, member 2 (EC:2.8.2.1) |
C00007446
|
6818 | SULT1A3, HAST, HAST3, M-PST, ST1A3/ST1A4, ST1A5, STM, TL-PST | sulfotransferase family, cytosolic, 1A, phenol-preferring, member 3 (EC:2.8.2.1) |
C00007446
|
6822 | SULT2A1, DHEA-ST, DHEAS, HST, ST2, ST2A1, ST2A3, STD, hSTa | sulfotransferase family, cytosolic, 2A, dehydroepiandrosterone (DHEA)-preferring, member 1 (EC:2.8.2.14) |
C00007446
|
OMIM | preferred title | UniProt |
---|---|---|
#216900 | Achromatopsia 2; achm2 |
Q16281
|
#614613 | Acrodysostosis 2, with or without hormone resistance; acrdys2 |
Q08499
|
#117800 | Apocrine gland secretion, variation in |
Q96J66
|
#301835 | Arts syndrome; arts |
P60891
|
#608584 | Asthma-related traits, susceptibility to, 2 |
Q6W5P4
|
#210900 | Bloom syndrome; blm |
P54132
|
#211800 | Calcification of joints and arteries; calja |
P21589
|
#115200 | Cardiomyopathy, dilated, 1a; cmd1a |
P02545
|
#212112 | Cardiomyopathy, dilated, with hypergonadotropic hypogonadism |
P02545
|
#605588 | Charcot-marie-tooth disease, axonal, type 2b1; cmt2b1 |
P02545
|
#311070 | Charcot-marie-tooth disease, x-linked recessive, 5; cmtx5 |
P60891
|
#304500 | Deafness, x-linked 1; dfnx1 |
P60891
|
#609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
#608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
#181350 | Emery-dreifuss muscular dystrophy 2, autosomal dominant; edmd2 |
P02545
|
#229700 | Fructose-1,6-bisphosphatase deficiency |
P09467
|
#612933 | Glycogen storage disease xi; gsd11 |
P00338
|
#605130 | Hairy elbows, short stature, facial dysmorphism, and developmental delay |
Q03164
|
#610140 | Heart-hand syndrome, slovenian type |
P02545
|
#176670 | Hutchinson-gilford progeria syndrome; hgps |
P02545
|
#146300 | Hypophosphatasia, adult |
P05186
|
#241510 | Hypophosphatasia, childhood |
P05186
|
#241500 | Hypophosphatasia, infantile |
P05186
|
#614128 | Lactate dehydrogenase b deficiency; ldhbd |
P07195
|
#151660 | Lipodystrophy, familial partial, type 2; fpld2 |
P02545
|
#248370 | Mandibuloacral dysplasia with type a lipodystrophy; mada |
P02545
|
#613205 | Muscular dystrophy, congenital, lmna-related |
P02545
|
#159001 | Muscular dystrophy, limb-girdle, type 1b; lgmd1b |
P02545
|
#254210 | Myasthenic syndrome, congenital, associated with episodic apnea |
P28329
|
#300661 | Phosphoribosylpyrophosphate synthetase superactivity |
P60891
|
#275210 | Restrictive dermopathy, lethal |
P02545
|
#613756 | Retinitis pigmentosa 49; rp49 |
P29973
|
#604906 | Schizophrenia 9; sczd9 |
P49798
|
#181500 | Schizophrenia; sczd |
P49798
|
#253300 | Spinal muscular atrophy, type i; sma1 |
Q16637
|
#253550 | Spinal muscular atrophy, type ii; sma2 |
Q16637
|
#253400 | Spinal muscular atrophy, type iii; sma3 |
Q16637
|
#271150 | Spinal muscular atrophy, type iv; sma4 |
Q16637
|
#188570 | Thyroid hormone resistance, generalized, autosomal dominant; grth |
P10828
|
#274300 | Thyroid hormone resistance, generalized, autosomal recessive; grth |
P10828
|
#145650 | Thyroid hormone resistance, selective pituitary; prth |
P10828
|
#278750 | Xeroderma pigmentosum, variant type; xpv |
Q9Y253
|
KEGG | name | UniProt |
---|---|---|
H00069 | Glycogen storage diseases (GSD) |
P00338
(related)
|
H00010 | Multiple myeloma |
P00338
(marker)
P07195 (marker) |
H00023 | Testicular cancer |
P00338
(marker)
P07195 (marker) |
H00035 | Ewing's sarcoma |
P00338
(marker)
P07195 (marker) |
H00043 | Neuroblastoma |
P00338
(marker)
P07195 (marker) |
H00264 | Charcot-Marie-Tooth disease (CMT) |
P02545
(related)
P60891 (related) |
H00294 | Dilated cardiomyopathy (DCM) |
P02545
(related)
|
H00420 | Familial partial lipodystrophy (FPL) |
P02545
(related)
|
H00563 | Emery-Dreifuss muscular dystrophy |
P02545
(related)
|
H00590 | Congenital muscular dystrophies (CMD/MDC) |
P02545
(related)
|
H00593 | Limb-girdle muscular dystrophy (LGMD) |
P02545
(related)
|
H00601 | Hutchinson-Gilford progeria syndrome |
P02545
(related)
|
H00663 | Restrictive dermopathy |
P02545
(related)
|
H00665 | Mandibuloacral dysplasia |
P02545
(related)
|
H01216 | Left ventricular noncompaction (LVNC) |
P02545
(related)
|
H00213 | Hypophosphatasia |
P05186
(related)
|
H00036 | Osteosarcoma |
P08684
(marker)
|
H00114 | Fructose-1,6-bisphosphatase deficiency |
P09467
(related)
|
H00249 | Thyroid hormone resistance syndrome |
P10828
(related)
|
H01205 | Coumarin resistance |
P11712
(related)
|
H00824 | Calcification of joints and arteries |
P21589
(related)
|
H00770 | Congenital myasthenic syndrome |
P28329
(related)
|
H00527 | Retinitis pigmentosa (RP) |
P29973
(related)
|
H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
H00094 | DNA repair defects |
P54132
(related)
|
H00296 | Defects in RecQ helicases |
P54132
(related)
|
H00196 | Phosphoribosylpyrophosphate synthetase I superactivity |
P60891
(related)
|
H00946 | Arts syndrome |
P60891
(related)
|
H01209 | Deafness, X-linked |
P60891
(related)
|
H00001 | Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia) |
Q03164
(related)
Q03164 (marker) |
H00002 | Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia) |
Q03164
(related)
|
H00971 | Achromatopsia |
Q16281
(related)
|
H00455 | Spinal muscular atrophy (SMA) |
Q16637
(related)
|
H00403 | Disorders of nucleotide excision repair |
Q9Y253
(related)
|
MESH or OMIM | name |
KNApSAcK
metabolite |
---|---|---|
D020326 | Migraine without Aura |
C00001497
C00019673 |
D004409 | Dyskinesia, Drug-Induced |
C00001497
C00019673 |
D006930 | Hyperalgesia |
C00001497
C00019673 |
D006973 | Hypertension |
C00001497
C00019673 |
D013375 | Substance Withdrawal Syndrome |
C00001497
C00019673 |
D001249 | Asthma |
C00001497
|
D014202 | Tremor |
C00001497
|
D006333 | Heart Failure |
C00019673
|
D008881 | Migraine Disorders |
C00019673
|